Challenges to malaria vaccine availability and successful implementation of malaria vaccine program in Africa

The approval of malaria vaccines was a significant milestone towards malaria eradication in Africa which bear the major burden of the disease. Ensuring availability and access to these vaccines across Africa however, presents complex challenges that limit their immediate impact. This review looks at the main obstacles to malaria vaccine availability and successful implementation of malaria vaccine program in Africa using academic and health databases. Supply constraints appear to be the major factor, as the current manufacturing capacity was insufficient to meet the high demand across endemic regions in Africa. Moreover, vaccine coverage in Africa is also impacted by limited national health budget that pose constraints to acquire, transport, store and conduct immunization activities. Lack of confidence in healthcare system, misinformation and conspiracy theory about vaccine efficacy and safety frequently propagated through social networks, community and religious leaders greatly affect public confidence about vaccine in societies where past experiences with Western-led health initiatives have led many to question new interventions. Programmatic and logistical hurdles, such as cold chain requirements and multiple-dose schedules further complicate delivery in remote area while shortages in skilled health workers and weak pharmacovigilance systems limit programme effectiveness. Finally, inequities in allocation risk leaving high-burden but resource-constrained regions underserved. Addressing these challenges require coordinated global and regional action, including scaling up manufacturing capacity, continuous research to enhance vaccine effectiveness, stable funding for production and distribution, strengthening health systems and fostering community trust to ensure that the potential of malaria vaccines to eliminate malaria from Africa is achieved.